Antibodies against polysaccharide type 3 and pneumococcal proteins demonstrate synergistic protective effect in a highly virulent type 3 invasive disease model in mice.
Saved in:
| Title: | Antibodies against polysaccharide type 3 and pneumococcal proteins demonstrate synergistic protective effect in a highly virulent type 3 invasive disease model in mice. |
|---|---|
| Authors: | Stevenson TC; GSK, Cambridge, MA, United States., Burke H; GSK, Cambridge, MA, United States., Roggensack SE; GSK, Cambridge, MA, United States., Pratt A; GSK, Cambridge, MA, United States., Hossain A; GSK, Cambridge, MA, United States., Ghosh P; Affinivax, Inc., Cambridge, MA, United States., Besin G; Affinivax, Inc., Cambridge, MA, United States., Lu Y; Division of Infectious Diseases, Department of Medicine, Boston Children's Hospital, Boston, MA, United States., Zhang F; Division of Infectious Diseases, Department of Medicine, Boston Children's Hospital, Boston, MA, United States., Malley R; Division of Infectious Diseases, Department of Medicine, Boston Children's Hospital, Boston, MA, United States., Sebastian S; GSK, Cambridge, MA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Dec 12; Vol. 16, pp. 1707686. Date of Electronic Publication: 2025 Dec 12 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1707686 |
